ArticleCardio-oncology (London, England)2025

Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors?

Patrick A Kwaah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.